Jazz Pharmaceuticals PLC

NAS:JAZZHealthcareNASDAQ:NBINASDAQ:NQUSMG

$208.43−0.86%At closeAt close · Tue 20 Oct · ≈ AED 765.46 · Market cap $13.53B · Next earnings Wed 4 Nov · Extended $209.00 +0.27%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	93.7%	85.8%	85.2%	88.6%	89.0%	88.2%	—	—
Operating margin	16.0%	5.5%	−1.8%	15.1%	17.6%	5.3%	5.3%	+0.0 pts
Net margin	10.1%	−10.6%	−6.1%	10.8%	13.8%	−8.3%	−8.3%	+0.0 pts
EBITDA margin	44.2%	33.2%	40.1%	37.8%	37.4%	2.5%	—	—
Return on equity	6.5%	−8.3%	−7.3%	11.1%	13.7%	−8.2%	−8.2%	+0.0 pts
Return on assets	3.7%	−2.7%	−2.1%	3.6%	4.7%	−3.1%	−3.1%	+0.0 pts
Return on capital employed	6.4%	1.5%	−0.7%	5.9%	6.5%	2.4%	—	—
Debt / equity	0.6×	1.6×	1.9×	1.5×	1.5×	1.3×	1.3×	+0.0%
Debt / assets	34.4%	50.0%	53.6%	50.8%	51.3%	46.5%	—	—
Interest coverage	3.8×	0.6×	−0.2×	2.0×	3.0×	1.2×	—	—
Current ratio	4.3×	3.2×	2.8×	2.2×	4.5×	1.9×	1.9×	+0.0%
Quick ratio	4.2×	1.9×	2.0×	1.8×	4.0×	1.7×	—	—
Cash ratio	1.6×	0.7×	0.9×	1.0×	2.3×	0.6×	0.6×	+0.0%
Asset turnover	0.4×	0.3×	0.3×	0.3×	0.3×	0.4×	—	—
Inventory turnover	1.6×	0.4×	0.8×	0.7×	0.9×	1.2×	—	—
Receivables turnover	6.0×	5.5×	5.6×	5.4×	5.7×	5.1×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated 31 Dec 2025 ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.